Clean Yield Group cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 17.1% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 702 shares of the company’s stock after selling 145 shares during the period. Clean Yield Group’s holdings in GE HealthCare Technologies were worth $52,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Bogart Wealth LLC increased its holdings in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares during the last quarter. Stonebridge Financial Group LLC increased its holdings in GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after purchasing an additional 222 shares during the last quarter. Olde Wealth Management LLC purchased a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $35,000. Finally, Zions Bancorporation National Association UT purchased a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $42,000. 82.06% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the company. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Citigroup lifted their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a report on Thursday, July 31st. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a report on Thursday, September 18th. Finally, Zacks Research upgraded GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $88.40.
GE HealthCare Technologies Price Performance
Shares of NASDAQ GEHC opened at $72.46 on Monday. The company has a market capitalization of $33.08 billion, a price-to-earnings ratio of 14.85, a price-to-earnings-growth ratio of 2.77 and a beta of 1.13. The business has a 50 day simple moving average of $74.35 and a 200-day simple moving average of $72.71. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm’s revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is presently 2.87%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories
- Five stocks we like better than GE HealthCare Technologies
- Investing in Construction Stocks
- SoundHound Breaks Critical Resistance: How High Can It Get Now?
- Profitably Trade Stocks at 52-Week Highs
- Klarna IPO: BNPL Stock or Something Bigger?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Teradyne Is a Core Play in the AI Hardware Boom
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.